Skip to main content

Mereo BioPharma Group plc

MREO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001719714

No open-market purchases or sales by Mereo BioPharma Group plc insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $18.0M in total; no superinvestor holds it.

Superinvestors holding MREO, Q2 2026

See all superinvestors

No superinvestor reported holding MREO in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of MREO each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2022

    0 superinvestors holding at quarter end

    Sold out
    HHLR Advisors (Hillhouse)